Testing effectiveness (Phase 2)Ended earlyNCT01720043What this trial is testingHemostatic Effects of VELCADE®* Treatment in Multiple Myeloma PatientsWho this might be right forMultiple Myeloma University of Utah 8
Testing effectiveness (Phase 2)Study completedNCT00095680What this trial is testingExtension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Scios, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT04356482What this trial is testingCONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19Who this might be right forCOVID-19SARS-CoV 2Convalescence+2 more Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 90
Testing effectiveness (Phase 2)Study completedNCT01056276What this trial is testingStudy to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose ChemotherapyWho this might be right forMultiple Myeloma SCRI Development Innovations, LLC 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279What this trial is testingTesting Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227What this trial is testingTesting AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Looking for participantsNCT07181941What this trial is testingResponse-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple MyelomaWho this might be right forRecurrent Multiple MyelomaRefractory Multiple Myeloma Fred Hutchinson Cancer Center 30
Early research (Phase 1)UnknownNCT03767725What this trial is testingAnti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Shenzhen Second People's Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT07649525What this trial is testingPersonalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness LevelWho this might be right forMultiple Myeloma (MM)Plasma Cell Leukemia (PCL) University of Leeds 1,226
Testing effectiveness (Phase 2)Looking for participantsNCT06581640What this trial is testingChimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple MyelomaRelapsed/Refractory The First Affiliated Hospital of Xiamen University 5
Large-scale testing (Phase 3)UnknownNCT00445497What this trial is testingEarly Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaWho this might be right forBrain and Central Nervous System TumorsLymphomaNeutropenia+3 more Clatterbridge Centre for Oncology 400
Testing effectiveness (Phase 2)Looking for participantsNCT07087860What this trial is testingTherapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder CancersWho this might be right forMetastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more Mayo Clinic 70
Large-scale testing (Phase 3)Enrolling By InvitationNCT06893250What this trial is testingOrthobiologic Treatment for Knee OsteoarthritisWho this might be right forOsteoarthritis Knee University Hospital of North Norway 160
Testing effectiveness (Phase 2)Study completedNCT00169559What this trial is testingDyslipidemia Study Investigating The Increase In "Good Cholesterol"Who this might be right forDyslipidaemias GlaxoSmithKline 250
Testing effectiveness (Phase 2)Study completedNCT01283997What this trial is testingPrevention of Treatment Induced Neuropathy in Multiple MyelomaWho this might be right forMyeloma M.D. Anderson Cancer Center 79
Not applicableStudy completedNCT04367610What this trial is testingEffects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated RejectionWho this might be right forAntibody-mediated RejectionKidney Transplant RejectionGraft Loss Istanbul University 75
Not applicableLooking for participantsNCT05968417What this trial is testingMyeloma Novel Drug Discovery Ver 1.2Who this might be right forMultiple Myeloma Institute of Cancer Research, United Kingdom 250
Not applicableStudy completedNCT06030089What this trial is testingPlasma Dosage of Venetoclax in the Fup of AML Patients Treated With Aza + VenWho this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire de Nice 20
Large-scale testing (Phase 3)UnknownNCT04000932What this trial is testingPlatelet Rich Plasma in Carpal Tunnel SyndromeWho this might be right forCarpal Tunnel Syndrome Baskent University 84
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168